Xuemei Luo

Sep 30, 2024 | medrxiv.org | Jia Chen |Xuemei Luo |Luyao Wang |Yiping Luo

The authors have declared no competing interest. No funding was received for this research. I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our analyses were based on publicly available data that had been approved by relevant review boards.

May 10, 2024 | mdpi.com | Ningning Wang |Xuemei Luo |Zhen Kun Wang |Jianguo Liu

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.

Dec 27, 2023 | bpspubs.onlinelibrary.wiley.com | Ying Xu |Jian Tang |Binbin Yuan |Xuemei Luo

ARC augmented renal clearance AVI avibactam BL β-lactam/β-lactamase inhibitor combination CAZ ceftazidime CAZ-AVI ceftazidime-avibactam CI continuous infusion CLCr creatinine clearance CRKP carbapenem-resistant Klebsiella pneumoniae CRPA carbapenem-resistant Pseudomonas aeruginosa Css steady-state concentration CVVHDF continuous venovenous haemodiafiltration DALI The Defining Antibiotic Levels in Intensive Care Unit Patients MDR multidrug-resistant MIC minimum inhibitory concentration PD...